Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 2 | 118 | 163 | 206 | 355 |
| Gross Profit | 2 | 118 | 163 | 206 | 355 |
| Operating Expenses | 3,119 | 3,506 | 4,248 | 3,432 | 4,452 |
| Operating Income | -3,117 | -3,388 | -4,086 | -3,226 | -4,097 |
| Other Income | 145 | 149 | 153 | 331 | 313 |
| Pre-tax Income | -2,972 | -3,239 | -3,933 | -2,895 | -3,784 |
| Net Income Continuous | -2,972 | -3,239 | -3,933 | -2,895 | -3,784 |
| Net Income | $-2,972 | $-3,239 | $-3,933 | $-2,895 | $-3,784 |
| EPS Basic Total Ops | -0.47 | -0.53 | -0.66 | -0.46 | -0.64 |
| EPS Basic Continuous Ops | -0.47 | -0.53 | -0.66 | -0.46 | -0.64 |
| EPS Diluted Total Ops | -0.47 | -0.53 | -0.66 | -0.46 | -0.64 |
| EPS Diluted Continuous Ops | -0.47 | -0.53 | -0.66 | -0.46 | -0.64 |
| EPS Diluted Before Non-Recurring Items | -0.47 | -0.53 | -0.66 | -0.49 | -0.64 |
| EBITDA(a) | $-3,112 | $-3,382 | $-4,080 | $-3,221 | $-4,092 |